| Hans-Günter Meyer-Thompson | Naloxon
USA. Exclusive: For the First Time, Harm Reduction Gets a Naloxone of Its Own
USA. Exclusive: For the First Time, Harm Reduction Gets a Naloxone of Its Own
In late April 2021, a manufacturing disruption brought Pfizer’s naloxone production to a standstill, leaving more than half the country’s harm reduction programs without access as overdose reached an all-time high. Now, a new naloxone product is being manufactured for harm reduction programs exclusively. (Filter, USA, 01.08.2022)
https://filtermag.org/naloxone-shortage-hikma-pfizer-remedy-alliance/